Articles about Cancer

Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics

Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup’s 3D microscope technology in clinical settings. Read More

Microsoft, Providence and UW create AI that unlocks tumor insights at a scale previously out of reach

Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods. Read More

Cancer AI Alliance says new tech platform will speed breakthroughs with novel privacy approach

A consortium of top U.S. cancer centers has developed an AI platform that trains models on clinical data from multiple institutions while protecting patient privacy, with the goal of cutting the timeline for new discoveries in cancer research from years to months. Read More

UW institute led by Nobel Laureate uses AI to develop ‘off switch’ for cancer drugs and other applications

The drug interleukin-2 does a great job of goosing a patient’s immune response to certain kidney and melanoma cancers. In… Read More

Startup spun out of Nobel Laureate’s lab teams with Eli Lilly to fight cancer with AI

Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More

Uncommon Thinkers: TerraPower Isotopes’ Chris Dunckley spearheads pursuit of ultra-rare element

Editor’s note: This series profiles five of the Seattle region’s “Uncommon Thinkers”: inventors, scientists, technologists and entrepreneurs transforming industries and driving positive… Read More

Bill Gates-backed TerraPower Isotopes produces rare, radioactive ingredient sought for cancer drugs

Nearly a decade ago, radio chemists at the nuclear power startup TerraPower saw a promising opportunity in radioactive waste from… Read More

Can AI cure cancer? New alliance unites tech giants and big research orgs in quest for breakthroughs

Four national cancer research organizations, spearheaded by Seattle’s Fred Hutch Cancer Center, will work together in an unprecedented alliance to… Read More

Illustration: Stylized microchip incorporating the look of a whole-slide pathology image

Microsoft, Providence and UW make use of generative AI for digital cancer diagnosis

Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for… Read More

Coding saves lives, and Fred Hutch Cancer Center wants the next generation to take note

Plenty of high school students plan to make careers out of coding when they graduate from college. And plenty of… Read More

After wife got cancer, Microsoft engineer built a tool to locate anti-COVID drug for immunocompromised

Rob Relyea set out to find information to help his wife. A longtime Microsoft engineer, Relyea had more than 28… Read More

Seattle biotech vet Justine Dell’Aringa sees parallels in science while building her own home

At home and at work, Justine Dell’Aringa is up for a challenge. The scientific associate director of Translational Research for… Read More

Concure Oncology raises $2M to bring innovative breast cancer radiation therapy to more patients

Concure Oncology has raised $2 million in new funding, helping to fuel growth for the Mercer Island, Wash.-based startup and… Read More

Phase Genomics lands $3.9M in grants to improve testing for chromosomal abnormalities

Seattle biotech company Phase Genomics announced Wednesday that it received two National Institutes of Health (NIH) grants totaling $3.9 million.… Read More

Podcast

Interview: New Fred Hutch president on the fight against cancer, and the tech industry’s central role

Dr. Thomas Lynch is in his first week as the new leader of the Fred Hutchinson Cancer Research Center, but… Read More

Scientists link mysterious snippets of DNA to cell growth and tumor suppression

Why do some strings of genetic code remain virtually unchanged despite tens of millions of years of evolutionary divergence? A… Read More

Thin metal films loaded with immune cells show promise as cancer therapy

Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells… Read More

Concure Oncology raises cash for breast cancer treatment that uses radioactive seeds

New funding: Concure Oncology is raising investment for its Breast Microseed treatment, which helps to prevent breast cancer from recurring.… Read More

Backed by Bill Gates, TerraPower branches out into radioisotopes for cancer treatment

TerraPower, the nuclear research venture founded by Bill Gates, is joining with Isotek Systems and the U.S. Department of Energy… Read More

Microsoft and Jackson Lab tackle cancer genetics with ‘human-computer symbiosis’

The rise of therapies that target tumors based on their genetic profile is revolutionizing how we treat cancer. It’s also… Read More

Seattle Genetics stock jumps 17% on breast cancer drug trial success

Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new… Read More

Seattle Children’s opens a ‘cure factory’ to explore treatments for childhood cancer and other diseases

Maryn Sage remembers the words she heard on the day she learned that her 16-year-old son, Jedd Feliciano, was cancer-free.… Read More

Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors

Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that… Read More

Navigating Cancer raises $26M, aims to change the patient experience for oncology care

Navigating Cancer, a Seattle startup that makes software to help providers and patients manage cancer treatment, landed $26 million in… Read More

Can games improve your mental health? PAX panel explores the rise of games as a coping mechanism

Video games are surrounded by a stigma that they are inherently bad from a mental health perspective. This negative perception… Read More

Adaptive Biotechnologies will triple size of its Seattle HQ following IPO

Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More

Cancer-fighting startup Neoleukin merging with Aquinox in $40M deal, 8 months after UW spinout

Vancouver, B.C.-based Aquinox Pharmaceuticals is set to buy Neoleukin Therapeutics, a Seattle startup that launched out of the University of… Read More

Cancer drugmaker Seattle Genetics raises $575 million in stock offering

Seattle Genetics sold more than 8 million shares in a stock offering that brought in $575 million for the company… Read More

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

The question of why immunotherapy eradicates cancer in some people while having little effect on the majority of patients has… Read More

Seattle Genetics shares rise on strong Adcetris sales, $218M in revenue for Q2

Cancer drugmaker Seattle Genetics reported stronger-than-expected revenues for the second quarter as its stock rose more than 8 percent in… Read More